Stock 455 TIANDA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Tianda Pharmaceuticals Limited

Equities

455

KYG887471038

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 01:38:22 29/04/2024 pm IST 		5-day change 1st Jan Change
0.26 HKD -1.89% Intraday chart for Tianda Pharmaceuticals Limited 0.00% +19.27%
26/03 Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
21/03 Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023 CI

Business Summary

Tianda Pharmaceuticals Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The Company operates businesses in Hong Kong, China and Australia.

Number of employees: 863

Sales per Business

HKD in Million2022Weight Delta
Pharmaceuticals and Medical Technologies
84.1 %
460 84.1 % -
Chinese Medicine
13.2 %
72 13.2 % -
Medical and Healthcare Services
2.7 %
15 2.7 % -

Sales per region

HKD in Million2022Weight Delta
China
98.4 %
538 98.4 % -
Hong Kong
1.4 %
8 1.4 % -
Australia
0.2 %
1 0.2 % -

Managers

Managers TitleAgeSince
Wen Quan Fang CEO
 Chief Executive Officer 55 01/03/01
Tai On Lo SEC
 Corporate Secretary 69 -

Members of the board

Members of the board TitleAgeSince
Sung Hong Chiu BRD
 Director/Board Member 77 10/08/10
Yat Fai Lam BRD
 Director/Board Member 58 01/04/01
Wen Quan Fang CEO
 Chief Executive Officer 55 01/03/01
Tao Zhong BRD
 Director/Board Member 52 29/23/29
Man Sang Lui BRD
 Director/Board Member 60 01/13/01
Quan Ming Feng BRD
 Director/Board Member 47 23/16/23
Xian Yanfang BRD
 Director/Board Member 43 27/23/27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,150,041,884 442,328,526 ( 20.57 %) 0 20.57 %

Shareholders

NameEquities%Valuation
Wen Quan Fang
56.72 %
1,219,579,370 56.72 % 41 M $
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
13.05 %
280,517,724 13.05 % 9 M $
Government of China
9.656 %
207,616,264 9.656 % 7 M $

Company contact information

Tianda Pharmaceuticals Ltd.

CITIC Tower No. 1 Tim Mei Avenue, Central

, Hong Kong

+

http://www.tiandapharma.com
address Tianda Pharmaceuticals Limited(455)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
TIANDA PHARMACEUTICALS LIMITED Stock Tianda Pharmaceuticals Limited
+19.27% 72.78M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 332B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.04% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 455 Stock
  4. Company Tianda Pharmaceuticals Limited